Avastin 400 mg Injection

Avastin 400 mg Injection contains bevacizumab, a monoclonal antibody used in the treatment of several types of cancer. It works by blocking VEGF, a protein that promotes the formation of blood vessels supplying tumors. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Avastin 400 mg Injection is supplied as a preservative-free, single-use vial containing 400 mg of bevacizumab in 16 mL. It is used in approved treatment regimens for conditions including colorectal cancer, non-squamous non-small cell lung cancer, renal cell carcinoma, glioblastoma, and certain ovarian cancers. Bevacizumab binds to VEGF and inhibits tumor-associated blood vessel formation, which can help limit tumor growth. The product is formulated as a concentrate for intravenous infusion and should be used according to the prescribed oncology treatment protocol.

Technical Specification

Specification Details
Active Ingredient Bevacizumab 400 mg
Concentration 25 mg/mL
Vial Volume 16 mL
Dosage Form Concentrate for Solution for Infusion
Route of Administration Intravenous Infusion
Presentation Single-Use Vial

Product Also Known As

Avastin 400 mg Injection, Avastin 400 mg/16 mL Injection, Avastin Bevacizumab 400 mg Injection, Bevacizumab 400 mg Injection, Bevacizumab 400 mg Infusion, Bevacizumab Oncology Injection